- Home
- DLPN vs SNSE Comparison
DLPN vs SNSE Comparison
Compare DLPN & SNSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DLPN
- SNSE
- Stock Information
- Founded
- DLPN N/A
- SNSE 2005
- Country
- DLPN United States
- SNSE United States
- Employees
- DLPN N/A
- SNSE N/A
- Industry
- DLPN Other Consumer Services
- SNSE Biotechnology: Pharmaceutical Preparations
- Sector
- DLPN Consumer Discretionary
- SNSE Health Care
- Exchange
- DLPN Nasdaq
- SNSE Nasdaq
- Market Cap
- DLPN 12.9M
- SNSE 12.3M
- IPO Year
- DLPN N/A
- SNSE 2021
- Fundamental
- Price
- DLPN $1.11
- SNSE $0.45
- Analyst Decision
- DLPN Strong Buy
- SNSE Strong Buy
- Analyst Count
- DLPN 1
- SNSE 3
- Target Price
- DLPN $5.00
- SNSE $4.33
- AVG Volume (30 Days)
- DLPN 49.8K
- SNSE 330.7K
- Earning Date
- DLPN 11-14-2024
- SNSE 11-14-2024
- Dividend Yield
- DLPN N/A
- SNSE N/A
- EPS Growth
- DLPN N/A
- SNSE N/A
- EPS
- DLPN N/A
- SNSE N/A
- Revenue
- DLPN $51,389,626.00
- SNSE N/A
- Revenue This Year
- DLPN $21.74
- SNSE N/A
- Revenue Next Year
- DLPN $7.26
- SNSE N/A
- P/E Ratio
- DLPN N/A
- SNSE N/A
- Revenue Growth
- DLPN 21.66
- SNSE N/A
- 52 Week Low
- DLPN $0.95
- SNSE $0.38
- 52 Week High
- DLPN $3.58
- SNSE $1.94
- Technical
- Relative Strength Index (RSI)
- DLPN 45.36
- SNSE 47.08
- Support Level
- DLPN $1.02
- SNSE $0.41
- Resistance Level
- DLPN $1.20
- SNSE $0.50
- Average True Range (ATR)
- DLPN 0.09
- SNSE 0.05
- MACD
- DLPN -0.00
- SNSE -0.00
- Stochastic Oscillator
- DLPN 26.47
- SNSE 34.09
About DLPN Dolphin Entertainment Inc.
Dolphin Entertainment Inc is an independent entertainment marketing and production company. It provides strategic marketing and publicity services to many of the top brands, both individual and corporate, in the motion picture, television, music, gaming, culinary, hospitality, and lifestyle industries. It operates in two reportable segments: Entertainment publicity and marketing and Content production. It generates the majority of its revenue from the Entertainment publicity and marketing segment which provides clients with diversified marketing services, including public relations, entertainment and hospitality content marketing, strategic marketing consulting, and content production of marketing materials.
About SNSE Sensei Biotherapeutics Inc.
Sensei Biotherapeutics Inc is an immuno-oncology company focused on the discovery and development of next-generation therapeutics for cancer patients. Its TMAb (Tumor Microenvironment Activated Biologics) platform developing highly selective therapeutics designed to disable immunosuppressive signals or activate immunostimulatory signals selectively in the tumor microenvironment. The company have four investigational product candidates in various stages of development: SNS-101, SNS-102, SNS-103, SNS-20.